HCP5 and breast cancer: A large number of studies have shown that overexpressed lncRNAs may promote BC progression by inhibiting ferroptosis, for example, lncRNA DSCAM-AS1 [30], lncRNA PTPRG-AS1 [31], and lncRNA HCP5 [32].